{
  "url": "https://openlegislation.uk/medicines-marketing-authorisations-etc-amendment-regulations-2005/schedule/paragraph-4",
  "json_url": "https://openlegislation.uk/medicines-marketing-authorisations-etc-amendment-regulations-2005/schedule/paragraph-4.json",
  "legislation": "uksi/2005/2759",
  "legislation_title": "The Medicines (Marketing Authorisations Etc.) Amendment Regulations 2005",
  "legislation_url": "https://openlegislation.uk/medicines-marketing-authorisations-etc-amendment-regulations-2005",
  "path": "schedule/paragraph/4",
  "kind": "paragraph",
  "number": "4",
  "heading": null,
  "text": "In the Genetically Modified Organisms (Risk Assessment) (Records and Exemptions) Regulations 1996, in regulation 3 (exemptions from requirement to carry out risk assessments), in paragraph (2)(c), after “Council Regulation (EEC) No 2309/93”, insert “or Regulation (EC) No. 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "S.I. 1996/1106."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2005/2759/schedule/paragraph/4",
    "retrieved_at": "2026-10-29T04:49:21.883121+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}